For the year ending 2025-12-31, ABEO made $5,820K in revenue. $71,313K in net income. Net profit margin of 1225.31%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Total revenues | 5,820 | |||
| Cost of sales | 1,532 | |||
| Royalties | 1,893 | |||
| Research and development | 26,812 | |||
| Selling, general and administrative | 65,031 | |||
| Total costs and expenses | 95,268 | |||
| Loss from operations | -89,448 | |||
| Interest income | 5,556 | |||
| Interest expense | 3,740 | |||
| Change in fair value of warrant and derivative liabilities | -6,139 | |||
| Gain from sale of priority review voucher, net | 152,366 | |||
| Other income, net | 410 | |||
| Income (loss) before income taxes | 71,283 | |||
| Income tax (benefit) expense | 100 | |||
| Net income (loss) | 71,183 | |||
| Change in unrealized gains related to available-for-sale debt securities | 130 | |||
| Comprehensive income (loss) | 71,313 | |||
| Basic EPS | 1.34 | |||
| Diluted EPS | 1.01 | |||
| Basic Average Shares | 52,952,917 | |||
| Diluted Average Shares | 66,135,821 | |||
ABEONA THERAPEUTICS INC. (ABEO)
ABEONA THERAPEUTICS INC. (ABEO)